Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-α in the liver

American Journal of Pathology

Volumn 154, Issue 4, 1999, Pages 1047-1055

  Sargent, Linda M ^a   Zhou, Xuan ^a   Keck, Catherine L ^a   Sanderson, Nancy D ^a   Zimonjic, Drazen B ^a   Popescu, Nicholas C ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; TRANSFORMING GROWTH FACTOR ALPHA;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME DELETION X; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOGENETICS; GENE OVEREXPRESSION; IN SITU HYBRIDIZATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUMERICAL CHROMOSOME ABERRATION; ONCOGENE C MYC; PRIORITY JOURNAL; STRUCTURAL CHROMOSOME ABERRATION; TRANSGENIC MOUSE;

EID: 0032899817     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65357-6     Document Type: Article

References (83)

1. Davies LM, Caspary WJ, Sakallah SE, Maronpot R, Wiseman R, Barrett JC, Elliott R, Hozier JC: Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis(Lond) 1994, 15:1637-1645
2. Adams J, Cory S: Transgenic models of tumor development. Science 1991, 254:1161-1166
3. Hanahan D: Dissecting multistep tumorigenesis in transgenic mice. Annu Rev Genet 1988, 22:479-519
4. Merlino G: Transgenic mice: designing genes for molecular models. The Liver: Biology and Pathobiology, ed 3. Edited by Arias I, Boyer J, Fausto N, Jakoby W, Schaler D. New York, Raven Press, 1994, pp 1579-1590
5. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL: Oncogene-induced liver neoplasia in transgenic mice. Oncogene 1989, 4:715-724
6. Jhappan Ch, Stahle CN, Harkins RN, Fausto N, Smith GH, Merlino GT: TGF-α over-expression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990, 61:1137-1146
7. Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC: Transforming growth factor α dramatically enhances oncogene induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993, 13:320-330
8. Murakami H, Sanderson N, Nagy P, Marino P, Merlino GT, Thorgeirs-son SS: Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res 1993, 53:1719-1723
9. Santoni-Rugiu E, Nagy P, Jensen MR, Factor V, Thorgeirsson SS: Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α Am J Pathol 1996, 149:401-428
10. Santoni-Rugiu E, Jensen MR, Thorgeirsson SS: Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α. Cancer Res 1998, 58:123-134
11. Sargent LM, Sanderson ND, Thorgeirsson SS: Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor α transgenes. Cancer Res 1996, 56:2137-2142
12. Yeh S-H, Chen P-J, Lai M-Y, Wang C-C, Chen D-S: Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 1994, 54:4188-4192
13. Wang HP, Rogler C: Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 1988, 48:72-78
14. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A, Govindarajah S: Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Genetics 1989, 86:8852-8856
15. Tsuda H, Zhang W, Shimasato Y: Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990, 87:6791-6794
16. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y: Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res 1992, 52:5368-5372
17. Zhang W, Hirohashi S, Tsuda H, Shimasato Y, Yokata J, Terada M, Sugimura T: Frequent loss of heterozygosity on chromosome 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 1990, 81: 108-111
18. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Yagura M, Matsubara K, Nakamura Y: Allelotype study of primary hepatocellular carcinoma. Cancer Res 1991, 51:89-93
19. Simon D, Knowles BB, Weith A: Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 1991, 6:765-770
20. Walker GJ, Hayward NK, Falvery S, Cooksley WGE: Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res 1991, 51: 4367-4370
21. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS: Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res 1994, 54:281-285
22. Zimonjic DB, Popescu NC, Matsui T, Ito M, Chihara K: Localization of the human cholecystokinin-B/gastrin receptor gene (CCKBR) to chromosome 11p15.5-p15.4 by fluorescence in situ hybridization. Cytogenet Cell Genet 1994, 65:184-185
23. Zimonjic DB, Rezanka L, Di Paolo JA, Popescu NC: Refined localization of the erbB-3 proto-oncogene by direct visualization of FISH signals on LUT-inverted and contrast-enhanced digital images of DAPI-banded chromosomes. Cancer Genet Cytogenet 1995, 80: 100-102
24. Cowell JK: A photographic representation of the variability in the G-banded structure of the chromosomes in the mouse karyotype. Chromosoma 1984, 89:294-320
25. Bennett ML, Drinkwater NR: Localization of the Htm gene to the distal region of mouse chromosome one. Proc Am Assoc Cancer Res 1993, 34:144
26. Lee G-H, Bennett LM, Carabao RA, Drinkwater NR: Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics 1995, 139:387-395
27. Drinkwater NR: Genetic control of hepatocarcinogenesis in C3H mice. Drug Metab Rev 1994, 26:201-208
28. Van Wezel T, Stassen AP, Moen CJ, Hart AA, van der Vvalk MA, Demant P: Gene interaction and single gene effects in colon tumour susceptibility in mice. Nature Genet 1996, 14:468-470
29. Herzog CR, Chen B, Wang Y, Schut HAJ, You M: Loss of heterozygosity on chromosomes 1, 11, 12 and 14 in hybrid mouse lung adenocarcinomas. Mol Carcinog 1996, 16:83-90
30. Seldin MF, Kruh GD: Mapping of ABII within a conserved linkage group on distal mouse chromosome 1 syntenic with human chromosome using an interspecific cross. Genomics 1989, 4:221-223
31. Hoopes CW, Taketo M, Ozato K, Liu Q, Howard TA, Linney E, Seldin MF: Mapping of the mouse Rxr loci encoding nuclear retinoid X receptors RXR α, RXR β, and RXR γ. Genomics 1992, 14:611-617
32. Testa JR, Zhou J-Y, Bell DW, Yen TJ: Chromosomal localization of the genes encoding the kinetochore proteins CENPE and CENPF to human chromosomes 4q24-25 and 1q32-q41, respectively by fluorescence in situ hybridization. Genomics 1994, 23:691-693
33. Lafuse WP, Brown D, Zwilling BS: Assignment of the microtubule-associated protein 2 gene to mouse chromosome 1. Mammalian Genome 1992, 3:48-51
34. Mulleer-Sieburg CE, Riblet R: Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J Exp Med 1996, 183:141-150
35. Sargent LM, Xu HY, Sattler GL, Meisner LF, Pitot HC: Ploidy and karyotype of hepatocytes isolated from enzyme-altered foci in two different protocols of multistage hepatocarcinogenesis in the rat. Carcinogenesis 1989, 10:387-391
36. Saeter G, Schwarze PE, Nesland JM, Juul N, Pettersen EO, Seglen PO: The polyploidizing growth of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas. Carcinogenesis 1988, 9:939-945
37. Lowickhik A, Schneider NR, Tonk V, Ansari MQ, Timmons CF: Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics. Cancer Genet Cytogenet 1995, 88:170-174
38. Rabbits TH: Chromosomal translocations in human cancers. Nature 1994, 372:143-149
39. Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y: Evidence for the presence of two tumor-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer 1995, 72:383-385
40. Katagiri T, Yusuke N, Mik Y: Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res 1996, 56:4575-4577
41. Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW, Wiseman RW: Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 1994, 54:6257-6264
42. Aihara T, Noguchi S, Sasaki Y, Nakano H, Monden M, Imaoka S: Clonal analysis of precancerous lesion of hepatocellular carcinoma. Gastroenterology 1996, 111:455-461
43. Osawa N, Sakamoto M, Saito T, Kobayashi M, Hirohashi S: Numerical chromosome aberrations in hepatocellular carcinoma detected by fluorescence in situ hybridization. J Hepatol 1996, 25:655-662
44. Lee G-H, Ogawa K, Nishimori H, Drinkwater NR: Most liver epithelial cell lines from C3B6F1 mice exhibit parentally-biased loss of heterozygosity at the LCI (liver cell immortalization) locus on chromosome 4. Oncogene 1995, 11:2281-2287
45. Byrne JA, Smith PJ: The 11p15.5 ribonucleotide reductase M1 subunit locus is not imprinted in Wilms' tumor and hepatoblastoma. Hum Genet 1993, 91:275-277
46. Sargent LM, Dragan YP, Sattler G, Xu Y-H, Wiley JE, Pilot HC: Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms. Cancer Res 1997, 57:3451-3456
47. Albrecht S, von Schweinitz D, Waha A, Kraus JA, Vondeimling A, Pietsch T: Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res 1994, 54:5041-5044
48. Garibaldi M, Manenti G, Canaan F, Falvella FS, Pierotti MA, Porta GD, Binelli G, Dragani TA: Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res 1993, 53:209-211
49. Reynolds SH, Stowers SJ, Patterson RM, Maronpot RR: Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 1987, 237:1309-1316
50. Lee GH: Detection of activated c-H-ras oncogene in hepatocellular carcinomas developing in transgenic mice harboring albumin promoter-regulated simian virus 40 gene. Carcinogenesis 1990, 11: 1145-1148
51. Ohgaki H, Sanderson ND, Ton P, Thorgeirsson SS: Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-α double transgenic mice. Cancer Lett 1996, 106:43-49
52. Bremner R, Balmain A: Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 1990, 61:407-417
53. Held WA, Pazik J, Giancola J, O'Brien G, Kerns K, Gobey M, Mels R, Kenny L, Rustum Y: Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res 1994, 54:6489-6495
54. Casola S, Ungaro P, Redone PV, Lassaro D: Loss of heterozygosity of imprinted genes in SV40 t/T antigen induced hepatocellular carcinomas. Oncogene 1995, 11:711-721
55. Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Standbridge EJ: Introduction of a normal human chromosome 11 into Wilms' tumor cell line controls its tumorigenic expression. Science 1987, 236:175-180
56. Bhla M, Inoue H, Contticellis MG, Kastury K, Baffa R, Palazzo J, Siprashvili ZI, Mori M, McCue P, Druck T, Croce CM, Huebner K: The FHIT gene spanning the chromosome 3p14.2 fragile site, and renal carcinoma-associated t(34;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-597
57. Bonyadi M, Cui W, Nagase H, Akhurst RJ: The TGF β type II receptor, Tgfb2, maps to distal mouse chromosome 9. Genomics 1996, 33: 328-329
58. Mathew S, Murty VV, Cheifetz S, George D, Massague J, Chaganti RR: Transforming growth factor receptor gene TGFB2 maps to human chromosome band 3p22. Genomics 1994, 20:114-115
59. Sue SR, Chari RS, Kong FM, Mills JJ, Fine RL, Jirtle RL, Meyers WC: Transforming growth factor-β receptors and mannose 6-phosphate/ insulin-like growth factor II receptor expression in human hepatocellular carcinoma. Ann Surg 1995, 222:17-18
60. Miyasaka K, Ohtake K, Nomura K, Kanda H, Kominami R, Miyashita N, Kitagawa T: Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture. Mol Carcinog 1995, 13:37-43
61. Potter M, Mushinski EB, Wax JS, Hartley J, Mock BA: Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Cancer Res 1994, 54:969-975
62. Genuardi M, Tsihiara H, Anderson DE, Saunders GF: Distal deletion of chromosome 1p in ductal carcinoma of the breast. Am J Hum Genet 1989, 45:73-82
63. Bieche I, Champene MH, Matifas F, Cropp CS: Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 1993, 53:1990-1994
64. Jonasson J, Povey S, Harris H: The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci 1977, 24:217-254
65. Tanaka K, Yanoshita R, Konishi M, Oshimura M: Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene 1993, 8:2253-2258
66. Obata M, Lee GH, Kanda H, Kitagawa T, Ogawa K: Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts. Mol Carcinog 1998, 19:17-24
67. Belinsky SA, Swafford DS, Middleton SK, Kennedy CH, Tesfaigzi J: Deletion and differential expression of p16INK4a in mouse lung tumors. Carcinogenesis (Lond) 1997, 18:115-120
68. Maneti G, Garibaldi M, Fiorino A, Zanesi N, Pierotti MA, Dragani TA: Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res 1997, 57:4164-4166
69. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W: Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the nude mouse. Cell 1993, 75:631-639
70. Miyasaka K, Fukui T, Kitagawa T: Allelotype analysis in mouse hepatocellular carcinomas: frequent homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in culture. Biol Pharmaceut Bull 1996, 19:683-691
71. Wever B, Shen F, Prajada N, Yen YA, Yang H, Herenyiova M, Look KY: Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Res 1996, 16:3271-3281
72. Yamashita S, Ogawa M, Sakamato K, Abe T, Arakawa H, Yamashita J: Elevation of serum group II phospholipase A2 levels in patients with advanced cancer. Clin Chem Acta 1994, 228:91-99
73. Yamashita J, Ogawa M, Sakai K: Prognostic significance of three novel biologic factors in clinical trial of adjuvant therapy for node-negative breast cancer. Surgery 1995, 117:601-608
74. Yamashita S, Yamashita J, Ogawa M: Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency. Br J Cancer 1994, 69:1166-1170
75. Pathak S, Dave BJ, Gadhia PK: Mouse chromosome 14 is altered in different metastatic murine neoplasias. Cancer Genet Cytogenet 1995, 56:172-173
76. Rajput B, Marshal A, Killary AM, Lalley PA, Naylor SL, Belin D, Rickles RJ, Strickland S: Chromosomal assignments of genes for tissue plasminogen activator and urokinase in mouse. Somat Cell Mol Genet 1987, 13:581-586
77. Zhang X, Murakami Y, Sachse R, Yashima K, Hirohashi S, Hu SX, Benedict WF, Sekiya T: Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 1994, 54:4177-4182
78. Karhu R, Knuutila S, Kallioniemi OP, Stiltonen S, Aine R, Vilpo J: Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Genes Chromosomes & Cancer 1997, 19:286-290
79. Sato T, Tanigami A, Yamakawa K: Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990, 50:7184-7189
80. Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu HJ, Hu SX, Benedict WF, Sekiya T: Deletion of three distinct regions on chromosome 13q in human non-small cell lung cancer. Int J Cancer 1997, 74:45-49
81. Copeland NG, Jenkins NA, Gilbert DJ, Eppig JT: A genetic linkage map of the mouse: current applications and future prospects. Science 1993, 262:57-66
82. Yamasaki H, Mesnil M, Omori Y, Mironov N, Krutovskikh V: Intercellular communication and carcinogenesis. Mutat Res 1995, 333: 181-188
83. Searle AG, Peter J, Lyon MF, Evans EP, Edwards JH, Buckle VJ: Chromosome maps of man and mouse, III. Genomics 1987, 1:3-18